Cadrenal Therapeutics, Inc. , a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapies, leading with tecarfarin, a new Vitamin K antagonist will ...

Bristol-Myers Squibb (NYSE:BMY), a global biopharmaceutical giant with a market capitalization of $120.8 billion, finds ...

“Studies have shown that healthcare utilization at the end of life is high, and patients receive aggressive medical care that ...

Rodman & Renshaw initiated coverage on shares of biopharmaceutical company Talphera (NASDAQ: TLPH) with a Buy rating and a price target of $4.00. The firm's analysts highlighted Talphera's focus on ...

Despite California's statewide bans on toxic mouse and rat poison use, traces of these poisons are still being found in non-target wildlife species ... at least three were found to be exposed to ...

They may be prescribed before, during, or after surgery. There are two primary types of blood thinners: anticoagulants and antiplatelets. While they both prevent slow the formation of clots, they do ...

Target raised its fourth-quarter sales forecast Thursday after more consumers turned to its stores and website for holiday shopping — particularly on days known for deep discounts. The big-box ...

Objective After transcatheter aortic valve implantation (TAVI), the optimal regimen of anticoagulant therapy in patients with an additional indication for oral anticoagulation remains a matter of ...

Department of Cardiovascular Surgery, Affiliated Hospital of Southwest Jiaotong University, The General Hospital of Western Theater Command, Chengdu, China Background: Anticoagulants are the primary ...